About Sakurabashi Watanabe Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Sakurabashi Watanabe Hospital
During the past decade, Sakurabashi Watanabe Hospital conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 7 clinical trials were completed, i.e. on
average, 58.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection
1997-10-01
Completed
2,000
A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients
Completed
300
A Randomized Prospective Study of Pyrimethamine Therapy for Prevention of Toxoplasmic Encephalitis in HIV-Infected Individuals With Serologic Evidence of Latent Toxoplasma Gondii Infection
1992-03-01
Completed
600
A Randomized, Prospective, Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women
1995-12-01
Completed
400
A Randomized, Comparative, Prospective Study of Daily Trimethoprim / Sulfamethoxazole (TMS) and Thrice-Weekly TMS for Prophylaxis Against PCP in HIV-Infected Patients
1996-11-01
Completed
2,500
A Study of Psychosocial and Behavioral Determinants of Differential Rates of Participant Compliance in CPCRA Protocols
1994-10-01
1996-09-01
Completed
557
A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.
1998-10-01
Completed
525
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Sakurabashi Watanabe Hospital" #1 sponsor was "Boston Scientific Corporation" with 4 trials, followed by "Abbott Medical Devices" with 3 trials
sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "NewAmsterdam Pharma"
with 2 trials sponsored. Other sponsors include 4 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Sakurabashi Watanabe Hospital"
#1 collaborator was "Guidant Corporation" with 1 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator, "Medtronic" with 1 trials as a collaborator and "Medtronic Japan Co., Ltd." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Sakurabashi Watanabe Hospital
According to Clinical.Site data, the most researched conditions in "Sakurabashi Watanabe Hospital" are
"Coronary Artery Disease" (5 trials), "Heart Failure" (5 trials), "Atrial Fibrillation" (4 trials), "Angina Pectoris" (2 trials) and "Arrhythmias, Cardiac" (2 trials). Many other conditions were trialed in "Sakurabashi Watanabe Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Sakurabashi Watanabe Hospital
Most popular intervention types in "Sakurabashi Watanabe Hospital" are "Drug" (10 trials), "Device" (9 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Aspirin" (2 trials), "Dabigatran Etexilate 150mg" (2 trials), "Obicetrapib" (2 trials), "Placebo" (2 trials) and "ABSORB GT1 BVS" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Sakurabashi Watanabe Hospital
The vast majority of trials in "Sakurabashi Watanabe Hospital" are
22 trials for "All" genders.
Clinical Trials Status at Sakurabashi Watanabe Hospital
Currently, there are NaN active trials in "Sakurabashi Watanabe Hospital".
undefined are not yet recruiting,
5 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Sakurabashi Watanabe Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Sakurabashi Watanabe Hospital, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 4 trials that are defined as “Not Applicable".